You have 9 free searches left this month | for more free features.

sym004

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial in Worldwide (Sym004, Futuximab, Modotuximab)

Terminated
  • Metastatic Colorectal Cancer
  • +2 more
  • Sym004
  • +2 more
  • Duarte, California
  • +17 more
Sep 7, 2020

Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial (Sym004, TAS-102)

Withdrawn
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Jan 31, 2019

Metastatic Colorectal Cancer Trial in Spain, United States (Sym004, FOLFIRI)

Terminated
  • Metastatic Colorectal Cancer
  • Los Angeles, California
  • +7 more
Mar 14, 2019

Metastatic Colorectal Cancer Trial in Belgium, Spain, United States (Sym004)

Completed
  • Metastatic Colorectal Cancer
  • Sym004
  • San Antonio, Texas
  • +6 more
Sep 13, 2018

Carcinoma, Squamous Cell of Head and Neck Trial in Belgium, France, Germany (Sym004)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Sym004
  • Antwerp, Edegem, Belgium
  • +9 more
Sep 13, 2018

Solid Tumors Trial in Darmstadt (Sym004)

Completed
  • Solid Tumors
  • Sym004
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center located in
Jul 19, 2017

Squamous NSCLC Trial (Sym004, Nivolumab)

Withdrawn
  • Squamous Non-Small Cell Lung Cancer
  • (no location specified)
Aug 25, 2017

Metastatic Colorectal Cancer Trial (Sym004)

Withdrawn
  • Metastatic Colorectal Cancer
  • Sym004
  • (no location specified)
Jan 31, 2017